These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 37494836

  • 1. Human umbilical cord-derived mesenchymal stromal cells alleviate liver cirrhosis through the Hippo/YAP/Id1 pathway and macrophage-dependent mechanism.
    Yao L, Hu X, Yuan M, Liu P, Zhang Q, Wang Z, Chen P, Xiong Z, Wu L, Dai K, Jiang Y.
    Int Immunopharmacol; 2023 Oct; 123():110456. PubMed ID: 37494836
    [Abstract] [Full Text] [Related]

  • 2. Human umbilical cord mesenchymal stem cells inhibit liver fibrosis via the microRNA-148a-5p/SLIT3 axis.
    Yuan M, Yao L, Chen P, Wang Z, Liu P, Xiong Z, Hu X, Li L, Jiang Y.
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111134. PubMed ID: 37918086
    [Abstract] [Full Text] [Related]

  • 3. In vivo hepatic differentiation potential of human umbilical cord-derived mesenchymal stem cells: Therapeutic effect on liver fibrosis/cirrhosis.
    Zhang GZ, Sun HC, Zheng LB, Guo JB, Zhang XL.
    World J Gastroenterol; 2017 Dec 14; 23(46):8152-8168. PubMed ID: 29290652
    [Abstract] [Full Text] [Related]

  • 4. Anti-TGFβ-1 receptor inhibitor mediates the efficacy of the human umbilical cord mesenchymal stem cells against liver fibrosis through TGFβ-1/Smad pathway.
    Xuan J, Feng W, An ZT, Yang J, Xu HB, Li J, Zhao ZF, Wen W.
    Mol Cell Biochem; 2017 May 14; 429(1-2):113-122. PubMed ID: 28181132
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Human umbilical cord-derived mesenchymal stem cells attenuate hepatic stellate cells activation and liver fibrosis.
    Shi X, Zhang K, Qi Q, Zhou W, Yu F, Zhang Y.
    Mol Biol Rep; 2024 Jun 14; 51(1):734. PubMed ID: 38874773
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic efficacy and in vivo distribution of human umbilical cord-derived mesenchymal stem cell spheroids transplanted via B-Ultrasound-guided percutaneous portal vein puncture in rhesus monkey models of liver fibrosis.
    Li S, Fu X, Wang J, Yang H, Wang D, Dong X, Duan Y, Wang H, Yan Y, Si W.
    Stem Cell Res Ther; 2024 Sep 19; 15(1):315. PubMed ID: 39300579
    [Abstract] [Full Text] [Related]

  • 11. Human Umbilical Cord Mesenchymal Stem Cells Promote Anti-Inflammation and Angiogenesis by Targeting Macrophages in a Rat Uterine Scar Model.
    Yang Q, Huang J, Liu Y, Mai Q, Zhou Y, Zhou L, Zeng L, Deng K.
    Stem Cell Rev Rep; 2024 Aug 19; 20(6):1555-1568. PubMed ID: 38703310
    [Abstract] [Full Text] [Related]

  • 12. Endogenous Follistatin-like 1 guarantees the immunomodulatory properties of mesenchymal stem cells during liver fibrotic therapy.
    Zheng X, Zhou X, Ma G, Yu J, Zhang M, Yang C, Hu Y, Ma S, Han Z, Ning W, Jin B, Zhou X, Wang J, Han Y.
    Stem Cell Res Ther; 2022 Aug 05; 13(1):403. PubMed ID: 35932064
    [Abstract] [Full Text] [Related]

  • 13. Reduction of Emphysema Severity by Human Umbilical Cord-Derived Mesenchymal Stem Cells in Mice.
    Laiman V, Lee YL, Hou YW, Fang YT, Chen YY, Lo YC, Heriyanto DS, Lan SC, Chen CL, Chen XY, Lee KY, Chang JH, Chuang HC.
    Int J Mol Sci; 2022 Aug 10; 23(16):. PubMed ID: 36012176
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. YAP-regulated type II alveolar epithelial cell differentiation mediated by human umbilical cord-derived mesenchymal stem cells in acute respiratory distress syndrome.
    Chen XY, Chen KY, Feng PH, Lee KY, Fang YT, Chen YY, Lo YC, Bhavsar PK, Chung KF, Chuang HC.
    Biomed Pharmacother; 2023 Mar 10; 159():114302. PubMed ID: 36701989
    [Abstract] [Full Text] [Related]

  • 16. Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) alleviate excessive autophagy of ovarian granular cells through VEGFA/PI3K/AKT/mTOR pathway in premature ovarian failure rat model.
    Dai W, Yang H, Xu B, He T, Liu L, Ma X, Ma J, Yang G, Si R, Pei X, Du X, Fu X.
    J Ovarian Res; 2023 Sep 30; 16(1):198. PubMed ID: 37777781
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.